1
POSTER PRESENTATION Open Access Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver Ninung RD Kusumawati * , Maria Mexitalia, Suci Romadhona, Agustini Utari From 7th APPES Biennial Scientific Meeting Nusa Dua, Bali. 14-17 November 2012 Obesity in children is becoming a global epidemic. Non- alcoholic fatty liver disease (NAFLD) is a highly prevalent and potentially serious complication of childhood obesity. Adiponectin level was decreased on obese children. Adipo- nectin is a protective factor against non-alcoholic fatty liver disease on obesity. The early identification of fibrosis is important in children with NAFLD in order to prevent the development of liver disease in adulthood. One of non-invasive procedure to predict liver fibrosis is the aspartate aminotransferase (AST)-platelet ratio index (APRI). The purpose of our study was to assess a correlation between APRI, adiponectin and body mass index (BMI) in obese children with fatty liver. A cross-sectional study was conducted from August to September 2007. Subjects were obese children from one junior high school in Semarang, Indonesia. Complete blood count, transaminase enzyme measurement, adipo- nectin level and abdominal ultrasound (USG) were performed on each subject. Only subjects with bright liver on USG underwent APRI analysis. Spearmans correlation was used for statistical analysis. Of 37 obese children, 19 children had bright liver on USG. The mean APRI was 0.16 (0.119). The mean Adipo- nectin was 4.04. Only one obese subject (5.0%) with bright liver had an APRI > 0.5. APRI was significantly correlated to alanine amino transferase (ALT) levels (r = 0.62), but not significantly correlated to BMI ( r = 0.35) and adiponectin (r = 0.45). There was no correlation between BMI, ALT (r = 0.16), AST (r = 0.16), and adiponectin (r = 0.30). This study suggest that obese children with fatty liver might have high APRI levels indicating the presence of liver fibrosis. However, there is no correlation between APRI, adiponectin and BMI. Published: 3 October 2013 doi:10.1186/1687-9856-2013-S1-P107 Cite this article as: Kusumawati et al.: Aspartate aminotransferase- platelet ratio index, adiponectin and body mass index in children with fatty liver. International Journal of Pediatric Endocrinology 2013 2013 (Suppl 1):P107. Submit your next manuscript to BioMed Central and take full advantage of: Convenient online submission Thorough peer review No space constraints or color figure charges Immediate publication on acceptance Inclusion in PubMed, CAS, Scopus and Google Scholar Research which is freely available for redistribution Submit your manuscript at www.biomedcentral.com/submit Department of Pediatric, Faculty of Medicine, Diponegoro University / Dr. Kariadi Hospital, Semarang, Indonesia Kusumawati et al. International Journal of Pediatric Endocrinology 2013, 2013(Suppl 1):P107 http://www.ijpeonline.com/content/2013/S1/P107 © 2013 Kusumawati et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children with fatty liver

Embed Size (px)

Citation preview

POSTER PRESENTATION Open Access

Aspartate aminotransferase-platelet ratio index,adiponectin and body mass index in childrenwith fatty liverNinung RD Kusumawati*, Maria Mexitalia, Suci Romadhona, Agustini Utari

From 7th APPES Biennial Scientific MeetingNusa Dua, Bali. 14-17 November 2012

Obesity in children is becoming a global epidemic. Non-alcoholic fatty liver disease (NAFLD) is a highly prevalentand potentially serious complication of childhood obesity.Adiponectin level was decreased on obese children. Adipo-nectin is a protective factor against non-alcoholic fattyliver disease on obesity. The early identification of fibrosisis important in children with NAFLD in order to preventthe development of liver disease in adulthood. One ofnon-invasive procedure to predict liver fibrosis is theaspartate aminotransferase (AST)-platelet ratio index(APRI). The purpose of our study was to assess acorrelation between APRI, adiponectin and body massindex (BMI) in obese children with fatty liver.A cross-sectional study was conducted from August to

September 2007. Subjects were obese children from onejunior high school in Semarang, Indonesia. Completeblood count, transaminase enzyme measurement, adipo-nectin level and abdominal ultrasound (USG) wereperformed on each subject. Only subjects with bright liveron USG underwent APRI analysis. Spearman’s correlationwas used for statistical analysis.Of 37 obese children, 19 children had bright liver on

USG. The mean APRI was 0.16 (0.119). The mean Adipo-nectin was 4.04. Only one obese subject (5.0%) with brightliver had an APRI > 0.5. APRI was significantly correlatedto alanine amino transferase (ALT) levels (r = 0.62), butnot significantly correlated to BMI (r = 0.35) andadiponectin (r = 0.45). There was no correlation betweenBMI, ALT (r = 0.16), AST (r = 0.16), and adiponectin (r =0.30).This study suggest that obese children with fatty liver

might have high APRI levels indicating the presence of

liver fibrosis. However, there is no correlation betweenAPRI, adiponectin and BMI.

Published: 3 October 2013

doi:10.1186/1687-9856-2013-S1-P107Cite this article as: Kusumawati et al.: Aspartate aminotransferase-platelet ratio index, adiponectin and body mass index in children withfatty liver. International Journal of Pediatric Endocrinology 2013 2013(Suppl 1):P107.

Submit your next manuscript to BioMed Centraland take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at www.biomedcentral.com/submitDepartment of Pediatric, Faculty of Medicine, Diponegoro University / Dr.

Kariadi Hospital, Semarang, Indonesia

Kusumawati et al. International Journal of Pediatric Endocrinology 2013, 2013(Suppl 1):P107http://www.ijpeonline.com/content/2013/S1/P107

© 2013 Kusumawati et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the CreativeCommons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, andreproduction in any medium, provided the original work is properly cited.